Piper Sandler on Tenaya Therapeutics Inc (TNYA): 'TN-301 Can Become a Key Value Driver for TNYA'

July 6, 2026 9:33 AM

Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $40.00 price target on Tenaya Therapeutics Inc (NASDAQ: TNYA).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found